Drug recall · August 13, 2014
Soliris recall
Why: Presence of Particulate Matter: Product failed the appearance for the presence of visible particles under labeled storage condition.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Soliris (eculizumab), 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial, Rx only, Manufactured by: Alexion Pharmaceuticals, Inc., Cheshire, CT 06410, NDC 25682-001-01, UPC 3 25682-001-01 6.
- Lots / codes
Lots: 10002-1, 00006-1, Exp 08/14; 10003A, Exp 11/14; 10004A, Exp 02/15; 10005A, 10005AR, 10007A, 10006A, Exp 07/15; and 10008A, Exp 08/15
- Quantity
- 96,506 vials
- Company
- Alexion Pharmaceuticals, Inc., Cheshire, CT
- Distribution
- Nationwide and Puerto Rico
- Initiated
- June 2, 2014 · Voluntary: Firm initiated
- Classified
- August 5, 2014
- Reported
- August 13, 2014
- Ended
- May 29, 2015
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.